Antibiotic resistance mechanisms among pediatric respiratory and enteric pathogens: A current update

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 969-973

  Brueggemann, Angela B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibiotic resistance; Mechanism; Moraxella catarrhalis; Pediatrics; Streptococcus pneumoniae

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; LINCOSAMIDE; MACROLIDE; METICILLIN; MIKAMYCIN B; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL GENETICS; BACTERIUM ISOLATE; CHILD CARE; DNA REPLICATION; DNA SYNTHESIS; DRUG TARGETING; ENTEROBACTERIACEAE; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; INTESTINE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; REVIEW; SEROPREVALENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 33749442870     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000239365.60595.d5     Document Type: Article

References (39)

1. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature. 2000;406:775-781.
2. Sheldon AT Jr. Antibiotic resistance: a survival strategy. Clin Lab Sci. 2005;18:170-180.
3. Huovinen P. Resistance to trimethoprim-sulfamethoxazole. Clin Infect Dis. 2001;32:1608-1614.
4. Pikis A, Dondersloot JA, Rodriquez WJ, Keith JM. A conservative amino acid mutation in the chromosome-encoded dihydrofolate reductase confers trimethoprim resistance in Streptococcus pneumoniae. J Infect Dis. 1998;178:700-706.
5. Woodford N. Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci. Clin Microbiol Infect. 2005;11(suppl 3):2-21.
6. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39:1211-1233.
7. Hawkey PM. Mechanisms of resistance to antibiotics. Intensive Care Med. 2000;36:S9-13.
8. Heilmann KP, Rice CL, Miller AL, et al. Decreasing prevalence of β-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother. 2005;49:2561-2564.
9. Rennie RP, Ibrahim KH. Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? commentary of antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. Clin Infect Dis. 2005;41:S234-238.
10. Wallace RJ Jr, Nash DR, Steingrube VA. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am J Med. 1990;88:465-505.
11. Richter SS, Winoker PL, Brueggemann AB, et al. Molecular characterization of the β-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 US medical centers during 1994-1995 and 1997-1998. Antimicrob Agents Chemother. 2000;44:444-446.
12. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-686.
13. Turner PJ. Extended-spectrum β-lactamases. Clin Infect Dis. 2005;41:S273-275.
14. Leverstein-van Hall MA, Box ATA, Blok HEM, Paauw A, Fluit AC, Verhoef J. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis. 2002;186:49-56.
15. Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49:2137-2139.
16. Paterson DL, Rossi F, Baquero F, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother. 2005;55:965-973.
17. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol. 1996;178:5853-5859.
18. Van Bambeke F, Glupczynski Y, Plesiat P, Pechere JC, Tulkens PM. Antibiotic efflux pumps in prokaryote cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother. 2003;51:1055-1065.
19. Roberts MC, Sutcliffe J, Courvalin P, Bogo Jensen L, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother. 1999;43:2823-2830.
20. Peric M, Bozdogan B, Jacobs MR, Appelbaum PC. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother. 2003;47:1017-1022.
21. Dowson CG, Hutchison A, Brannigan JA, et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A. 1989;86:8842-8846.
22. Munoz R, Dowson CG, Daniels M, et al. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol. 1992;6:2461-2465.
23. Hoban D, Baquero F, Reed V, Felmingham D. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int J Infect Dis. 2005;9:262-273.
24. Markowitz SM. Isolation of an ampicillin-resistant, non-β-lactamase- producing strain of Haemophilus influenzae. Antimicrob Agents Chemother. 1980;17:80-83.
25. Doern GV, Brueggemann AB, Pierce G, Holley HP Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292-297.
26. Hasegawa K, Chiba N, Kobayashi R, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob Agents Chemother. 2004;48:1509-1514.
27. Haas W, Kaushal D, Sublett J, Obert C, Tuomanen EI. Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae. J Bacteriol. 2005;187:8205-8210.
28. Brueggemann AB, Coffman SL, Rhomberg P, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in the United States since 1994-1995. Antimicrob Agents Chemother. 2002;46:680-688.
29. Farrell DJ, Morrissey I, Bakker S, Felmingham D. Molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 Study. J Antimicrob Chemother. 2002;50(suppl S1):39-47.
30. Farrell DJ, Jenkins SG, Brown SD, Patel M, Lavin BS, Klugman KP. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis. 2005;11:851-858.
31. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis. 2005;192:1988-1995.
32. De Groot R, Sluiter M, de Bruyn A, et al. Genetic characterization of trimethoprim resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1996;40:2131-2136.
33. Schito GC, Felmingham D. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003). Int J Antimicrob Agents. 2005;26:479-485.
34. Weill F-X, Fabre L, Grandry B, Grimont PAD, Casin I. Multiple-antibiotic resistance in Salmonella enterica serotype paratyphi B isolates collected in France between 2000 and 2003 is due mainly to strains harboring Salmonella genomic islands 1, 1-B, and 1-C. Antimicrob Agents Chemother. 2005;49:2793-2801.
35. Jain SK, Gupta A, Glanz B, Dick J, Siberry GK. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr Infect Dis J. 2005;24:494-497.
36. Spratt BG, Maiden MCJ. Bacterial population genetics, evolution and epidemiology. Philos Trans R Soc Lond B. 1999;354:701-710.
37. Maynard Smith J, Dowson CG, Spratt BG. Localised sex in bacteria. Nature. 1991;349:29-31.
38. Robinson DA, Enright MC. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2004;10:92-97.
39. Mohd-Zain Z, Turner SL, Cerdeno-Tarraga AM, et al. Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol. 2004;186:8114-8122.